BRIEF published on 10/24/2024 at 07:35, 1 year 3 months ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 1 year 3 months ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 1 year 4 months ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 4 months ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 1 year 6 months ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
PRESS RELEASE published on 07/11/2024 at 14:00, 1 year 6 months ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 1 year 8 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
PRESS RELEASE published on 05/28/2024 at 13:00, 1 year 8 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management, demonstrating commitment to client centricity and global business development Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Alliance Management
BRIEF published on 05/02/2024 at 14:15, 1 year 8 months ago Rentschler Biopharma Promotes Patrick Cushing as VP Operations for U.S. Subsidiary Operational Management Rentschler Biopharma Biopharmaceuticals Manufacturing Expansion Patrick Cushing
PRESS RELEASE published on 05/02/2024 at 14:10, 1 year 8 months ago Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary Rentschler Biopharma appoints Patrick Cushing as VP Operations for U.S. subsidiary, showcasing commitment to delivering high-quality services and expanding production capacity Expansion Rentschler Biopharma Biopharmaceutical Manufacturing Patrick Cushing VP Operations
Published on 01/30/2026 at 14:00, 1 hour 10 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 6 hours 35 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 7 hours 10 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 12 hours 55 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 15 hours 10 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 14:52, 17 minutes ago Edison issues report on Henderson Far East Income (HFEL)
Published on 01/30/2026 at 14:11, 58 minutes ago SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 1 hour 39 minutes ago North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada
Published on 01/30/2026 at 12:00, 3 hours 9 minutes ago HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 3 hours 15 minutes ago EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR
Published on 01/29/2026 at 18:00, 21 hours 10 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 21 hours 25 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 21 hours 25 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
